10.21037/apm-21-3472 Summary Keywords acute pancreatitis, traditional Chinese medicine, NLRP3, inflammation, antiinflammatory Citation He X, Xia J, Chen Q, Huang Z, Lu J and Ren Y (2025) An overview of current research on the modulation of NLRP3 inflammasome by traditional Chinese medicine to combat acute pancreatitis
Not everyone will be able to get these from their GP right away services are being rolled out slowly
In 2015, Glenmark was the first to launch the DPP4 inhibitor, Teneligliptin (Zita Plus and Ziten), followed by a FDC of Teneligliptin + Metformin (Zita-Met Plus and Ziten-M)
In addition to Ozempic, Novo Nordisk also manufacturers Rybelsus, an oral semaglutide used to treat type 2 diabetes